Skip to content

Study for the intestinal microflora remodeling and microRNA regulation mechanism of acupuncture in patients with functional constipation

Study for the intestinal microflora remodeling and microRNA regulation mechanism of acupuncture in patients with functional constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048831
Enrollment
Unknown
Registered
2021-07-18
Start date
2021-08-15
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Men or women aged 18-60 years; 2. According with Rome IV diagnostic criteria for functional constipation, with a history of constipation of at least half a year; 3. Severe constipation, complete spontaneous defecation <= 2 times a week, and has lasted for more than 3 months; 4. The patients had no special eating habits, anxiety, depression and other mental disorders; 5. At baseline, the patients had difficulty in defecation and dry stool (BSFS <= 3); Did not take any medicine for constipation, including intestinal microecology, probiotics, etc; 6. Did not receive acupuncture treatment for constipation in the past three months and lived in Chengdu or surrounding areas for a long time.

Exclusion criteria

Exclusion criteria: 1. History of abdominal or anorectal surgery; 2. Irritable bowel syndrome and organic or drug-induced constipation; Secondary to endocrine, metabolic or neurogenic constipation; 3. Patients with heart, liver, kidney damage or cognitive impairment, aphasia, or unable to cooperate with sample collection and treatment; 4. Pregnancy, lactation, postpartum and allergic constitution; 5. Coagulation dysfunction or anticoagulants such as farwarfarin and heparin have been used.

Design outcomes

Primary

MeasureTime frame
weekly complete spontaneous bowel movements;gut microbiota;microRNA;

Secondary

MeasureTime frame
weekly spontaneous bowel movements;Bristol Stool Form Scale;Difficulty in defecating;Patient Assessment Constipation Quality of Life;self-rating anxiety scale;self-rating depression scale;

Countries

China

Contacts

Public ContactLi Ying

Chengdu University of Traditional Chinese Medicine

liying@cdutcm.edu.cn+86 13708095607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026